227 related articles for article (PubMed ID: 18243431)
1. An HSV-1 gD mutant virus as an entry-impaired live virus vaccine.
Awasthi S; Lubinski JM; Eisenberg RJ; Cohen GH; Friedman HM
Vaccine; 2008 Feb; 26(9):1195-203. PubMed ID: 18243431
[TBL] [Abstract][Full Text] [Related]
2. B Virus (Macacine Herpesvirus 1) Divergence: Variations in Glycoprotein D from Clinical and Laboratory Isolates Diversify Virus Entry Strategies.
Patrusheva I; Perelygina L; Torshin I; LeCher J; Hilliard J
J Virol; 2016 Oct; 90(20):9420-32. PubMed ID: 27512063
[TBL] [Abstract][Full Text] [Related]
3. Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognition.
Uchida H; Shah WA; Ozuer A; Frampton AR; Goins WF; Grandi P; Cohen JB; Glorioso JC
J Virol; 2009 Apr; 83(7):2951-61. PubMed ID: 19129446
[TBL] [Abstract][Full Text] [Related]
4. A herpes simplex virus 2 glycoprotein D mutant generated by bacterial artificial chromosome mutagenesis is severely impaired for infecting neuronal cells and infects only Vero cells expressing exogenous HVEM.
Wang K; Kappel JD; Canders C; Davila WF; Sayre D; Chavez M; Pesnicak L; Cohen JI
J Virol; 2012 Dec; 86(23):12891-902. PubMed ID: 22993162
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, nectin-2, and 3-O-sulfated heparan sulfate but not with nectin-1.
Yoon M; Zago A; Shukla D; Spear PG
J Virol; 2003 Sep; 77(17):9221-31. PubMed ID: 12915538
[TBL] [Abstract][Full Text] [Related]
6. Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus.
Krummenacher C; Baribaud F; Ponce de Leon M; Baribaud I; Whitbeck JC; Xu R; Cohen GH; Eisenberg RJ
Virology; 2004 May; 322(2):286-99. PubMed ID: 15110526
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the antiviral potential among soluble forms of herpes simplex virus type-2 glycoprotein D receptors, herpes virus entry mediator A, nectin-1 and nectin-2, in transgenic mice.
Fujimoto Y; Tomioka Y; Ozaki K; Takeda K; Suyama H; Yamamoto S; Takakuwa H; Morimatsu M; Uede T; Ono E
J Gen Virol; 2017 Jul; 98(7):1815-1822. PubMed ID: 28671524
[TBL] [Abstract][Full Text] [Related]
9. Mutations in herpes simplex virus glycoprotein D that prevent cell entry via nectins and alter cell tropism.
Manoj S; Jogger CR; Myscofski D; Yoon M; Spear PG
Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12414-21. PubMed ID: 15273289
[TBL] [Abstract][Full Text] [Related]
10. Herpesvirus entry mediator and nectin-1 mediate herpes simplex virus 1 infection of the murine cornea.
Karaba AH; Kopp SJ; Longnecker R
J Virol; 2011 Oct; 85(19):10041-7. PubMed ID: 21795335
[TBL] [Abstract][Full Text] [Related]
11. Induction of conformational changes at the N-terminus of herpes simplex virus glycoprotein D upon binding to HVEM and nectin-1.
Lazear E; Whitbeck JC; Zuo Y; Carfí A; Cohen GH; Eisenberg RJ; Krummenacher C
Virology; 2014 Jan; 448():185-95. PubMed ID: 24314649
[TBL] [Abstract][Full Text] [Related]
12. A double mutation in glycoprotein gB compensates for ineffective gD-dependent initiation of herpes simplex virus type 1 infection.
Uchida H; Chan J; Goins WF; Grandi P; Kumagai I; Cohen JB; Glorioso JC
J Virol; 2010 Dec; 84(23):12200-9. PubMed ID: 20861246
[TBL] [Abstract][Full Text] [Related]
13. Role of Nectin-1 and Herpesvirus Entry Mediator as Cellular Receptors for Herpes Simplex Virus 1 on Primary Murine Dermal Fibroblasts.
Petermann P; Rahn E; Thier K; Hsu MJ; Rixon FJ; Kopp SJ; Knebel-Mörsdorf D
J Virol; 2015 Sep; 89(18):9407-16. PubMed ID: 26136572
[TBL] [Abstract][Full Text] [Related]
14. The herpes simplex virus receptor nectin-1 is down-regulated after trans-interaction with glycoprotein D.
Stiles KM; Milne RS; Cohen GH; Eisenberg RJ; Krummenacher C
Virology; 2008 Mar; 373(1):98-111. PubMed ID: 18076965
[TBL] [Abstract][Full Text] [Related]
15. Effects of linker-insertion mutations in herpes simplex virus 1 gD on glycoprotein-induced fusion with cells expressing HVEM or nectin-1.
Jogger CR; Montgomery RI; Spear PG
Virology; 2004 Jan; 318(1):318-26. PubMed ID: 14972557
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus serotype and entry receptor availability alter CNS disease in a mouse model of neonatal HSV.
Kopp SJ; Ranaivo HR; Wilcox DR; Karaba AH; Wainwright MS; Muller WJ
Pediatr Res; 2014 Dec; 76(6):528-34. PubMed ID: 25198371
[TBL] [Abstract][Full Text] [Related]
17. Reducing Viral Inhibition of Host Cellular Apoptosis Strengthens the Immunogenicity and Protective Efficacy of an Attenuated HSV-1 Strain.
Xu X; He Y; Fan S; Feng M; Jiang G; Wang L; Zhang Y; Liao Y; Li Q
Virol Sin; 2019 Dec; 34(6):673-687. PubMed ID: 31506828
[TBL] [Abstract][Full Text] [Related]
18. Entry mechanisms of herpes simplex virus 1 into murine epidermis: involvement of nectin-1 and herpesvirus entry mediator as cellular receptors.
Petermann P; Thier K; Rahn E; Rixon FJ; Bloch W; Özcelik S; Krummenacher C; Barron MJ; Dixon MJ; Scheu S; Pfeffer K; Knebel-Mörsdorf D
J Virol; 2015 Jan; 89(1):262-74. PubMed ID: 25320325
[TBL] [Abstract][Full Text] [Related]
19. Invasion of Herpes Simplex Virus 1 into Murine Dermis: Role of Nectin-1 and Herpesvirus Entry Mediator as Cellular Receptors during Aging.
Wirtz L; Möckel M; Knebel-Mörsdorf D
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826998
[TBL] [Abstract][Full Text] [Related]
20. Restoring Herpesvirus Entry Mediator (HVEM) Immune Function in HVEM
Tormanen K; Wang S; Jaggi U; Ghiasi H
J Virol; 2020 Jul; 94(16):. PubMed ID: 32522859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
